IPCA Labs Sept qtr PAT seen up 20% at Rs 78.4 cr
Dolat Capital has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, IPCA Labs September quarter net sales are expected to go up by 16.3% at Rs 602.7 crore, year-on-year, (YoY) basis.